Wenqi An

520 total citations
12 papers, 433 citations indexed

About

Wenqi An is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Wenqi An has authored 12 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Wenqi An's work include Influenza Virus Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Biosimilars and Bioanalytical Methods (2 papers). Wenqi An is often cited by papers focused on Influenza Virus Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Biosimilars and Bioanalytical Methods (2 papers). Wenqi An collaborates with scholars based in China, Italy and United States. Wenqi An's co-authors include Guanghui Ma, Xiaowei Ma, Zhiguo Su, Jie Wu, Aiying Guo, Shuoguo Li, Yufei Xia, Tao Wan, Wei Wei and Yiqun Du and has published in prestigious journals such as Nature Materials, Journal of Controlled Release and Pharmaceutical Research.

In The Last Decade

Wenqi An

11 papers receiving 430 citations

Peers

Wenqi An
Tülin Morçöl United States
Yifan Yu China
Douglas S. Watson United States
Jonathan K. Tsosie United States
Andrei N. Vzorov United States
Quinton M. Dowling United States
Wenqi An
Citations per year, relative to Wenqi An Wenqi An (= 1×) peers Vivian L. de Oliveira

Countries citing papers authored by Wenqi An

Since Specialization
Citations

This map shows the geographic impact of Wenqi An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqi An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqi An more than expected).

Fields of papers citing papers by Wenqi An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqi An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqi An. The network helps show where Wenqi An may publish in the future.

Co-authorship network of co-authors of Wenqi An

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqi An. A scholar is included among the top collaborators of Wenqi An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqi An. Wenqi An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kou, Zengqiang, Ti Liu, Bei Fan, et al.. (2024). A post-marketing study to evaluate the safety and immunogenicity of a quadrivalent influenza split-virion vaccine in elderly people aged 60 years and older. Tropical Diseases Travel Medicine and Vaccines. 10(1). 18–18.
2.
Li, Zhengjun, Yanli Yang, Xiaowei Ma, et al.. (2020). A biomimetic VLP influenza vaccine with interior NP/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy. Vaccine. 38(38). 5987–5996. 17 indexed citations
3.
Li, Maohua, Wenqi An, Lan Wang, et al.. (2019). Production of monoclonal antibodies for measuring Avastin and its biosimilar by Sandwich ELISA. Journal of Immunological Methods. 469. 42–46. 2 indexed citations
4.
Xia, Yufei, Jie Wu, Wei Wei, et al.. (2018). Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination. Nature Materials. 17(2). 187–194. 225 indexed citations
5.
Li, Zhengjun, Yanli Yang, Xiaowei Ma, et al.. (2018). Strong hydrophobicity enables efficient purification of HBc VLPs displaying various antigen epitopes through hydrophobic interaction chromatography. Biochemical Engineering Journal. 140. 157–167. 15 indexed citations
6.
Li, Maohua, Hongzhen Li, Kai Gao, et al.. (2017). A simple and cost-effective assay for measuring anti-drug antibody in human patients treated with Adalimumab. Journal of Immunological Methods. 452. 6–11. 8 indexed citations
7.
Sun, Lijing, Weiqing Zhou, Juan Li, et al.. (2015). Novel konjac glucomannan microcarriers for anchorage-dependent animal cell culture. Biochemical Engineering Journal. 96. 46–54. 14 indexed citations
8.
Ku, Zhiqiang, Qingwei Liu, Xiaohua Ye, et al.. (2014). A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine. 32(34). 4296–4303. 69 indexed citations
9.
Qiu, Shaohui, Qiang Wei, Zhenglun Liang, et al.. (2014). Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen. Human Vaccines & Immunotherapeutics. 10(8). 2350–2356. 8 indexed citations
10.
Zhang, Weifeng, Lianyan Wang, Yuan Liu, et al.. (2013). Comparison of PLA Microparticles and Alum as Adjuvants for H5N1 Influenza Split Vaccine: Adjuvanticity Evaluation and Preliminary Action Mode Analysis. Pharmaceutical Research. 31(4). 1015–1031. 38 indexed citations
11.
Huang, Qingrui, Dongxia Li, Wenqi An, et al.. (2013). PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine. Journal of Controlled Release. 172(1). 382–389. 33 indexed citations
12.
An, Wenqi, Penghui Yang, Yueqiang Duan, et al.. (2009). Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.. PubMed. 122(23). 2880–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026